1. Home
  2. TEVA vs A Comparison

TEVA vs A Comparison

Compare TEVA & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$36.61

Market Cap

40.5B

Sector

Health Care

ML Signal

HOLD

Logo Agilent Technologies Inc.

A

Agilent Technologies Inc.

HOLD

Current Price

$148.64

Market Cap

38.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEVA
A
Founded
1901
1999
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
40.5B
38.0B
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
TEVA
A
Price
$36.61
$148.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
15
Target Price
$38.63
$161.47
AVG Volume (30 Days)
5.5M
1.5M
Earning Date
04-29-2026
05-27-2026
Dividend Yield
N/A
0.92%
EPS Growth
183.45
3.16
EPS
N/A
2.27
Revenue
N/A
$4,472,000,000.00
Revenue This Year
N/A
$8.45
Revenue Next Year
$2.97
$6.13
P/E Ratio
N/A
$65.78
Revenue Growth
N/A
6.43
52 Week Low
$17.33
$108.35
52 Week High
$37.39
$160.27

Technical Indicators

Market Signals
Indicator
TEVA
A
Relative Strength Index (RSI) 66.67 69.79
Support Level $30.42 $135.76
Resistance Level $37.17 $151.38
Average True Range (ATR) 1.04 3.15
MACD 0.34 0.72
Stochastic Oscillator 88.48 90.46

Price Performance

Historical Comparison
TEVA
A

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Share on Social Networks: